Review cancer therapies and the eye-related side effects associated with antibody-drug conjugates (ADCs).

Identify and manage ocular adverse events related to ADCs through collaborative decision-making and patient case discussions.

Differentiate the roles of eye care professionals and oncologists in managing eye-related side effects and foster effective interdisciplinary collaboration.